As for solute carrier family-2-member-4-gene (SLC2A4), encoding glucose transporter-4-protein (GLUT4), it has been reported to serve as a novel therapeutic candidate for cancer treatment [50]. This evidence concerns the gene SLC4A2 and cancer.